HEADER TRANSFERASE/TRANSFERASE INHIBITOR 15-DEC-20 7L1X TITLE STRUCTURE OF HUMAN CK2 ALPHA KINASE (CATALYTIC SUBUNIT) WITH THE TITLE 2 INHIBITOR 108600. COMPND MOL_ID: 1; COMPND 2 MOLECULE: CASEIN KINASE II SUBUNIT ALPHA; COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: CATALYTIC SUBUNIT; COMPND 5 SYNONYM: CK II ALPHA; COMPND 6 EC: 2.7.11.1; COMPND 7 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: CSNK2A1, CK2A1; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562 KEYWDS INHIBITOR 108600, TRANSFERASE, TRANSFERASE-TRANSFERASE INHIBITOR KEYWDS 2 COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR O.RECHKOBLIT,A.K.AGGARWAL REVDAT 3 18-OCT-23 7L1X 1 REMARK REVDAT 2 25-AUG-21 7L1X 1 JRNL REVDAT 1 11-AUG-21 7L1X 0 JRNL AUTH K.SATO,A.A.PADGAONKAR,S.J.BAKER,S.C.COSENZA,O.RECHKOBLIT, JRNL AUTH 2 D.R.C.V.SUBBAIAH,J.DOMINGO-DOMENECH,A.BARTKOWSKI,E.R.PORT, JRNL AUTH 3 A.K.AGGARWAL,M.V.RAMANA REDDY,H.Y.IRIE,E.PREMKUMAR REDDY JRNL TITL SIMULTANEOUS CK2/TNIK/DYRK1 INHIBITION BY 108600 SUPPRESSES JRNL TITL 2 TRIPLE NEGATIVE BREAST CANCER STEM CELLS AND JRNL TITL 3 CHEMOTHERAPY-RESISTANT DISEASE. JRNL REF NAT COMMUN V. 12 4671 2021 JRNL REFN ESSN 2041-1723 JRNL PMID 34344863 JRNL DOI 10.1038/S41467-021-24878-Z REMARK 2 REMARK 2 RESOLUTION. 1.80 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.8.0267 REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.80 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 24.88 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 96.9 REMARK 3 NUMBER OF REFLECTIONS : 26802 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.175 REMARK 3 R VALUE (WORKING SET) : 0.173 REMARK 3 FREE R VALUE : 0.221 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.000 REMARK 3 FREE R VALUE TEST SET COUNT : 1418 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 1.80 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 1.85 REMARK 3 REFLECTION IN BIN (WORKING SET) : 1536 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 74.59 REMARK 3 BIN R VALUE (WORKING SET) : 0.2620 REMARK 3 BIN FREE R VALUE SET COUNT : 67 REMARK 3 BIN FREE R VALUE : 0.2480 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 2746 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 60 REMARK 3 SOLVENT ATOMS : 221 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 34.83 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -1.72000 REMARK 3 B22 (A**2) : 1.27000 REMARK 3 B33 (A**2) : 0.55000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : -0.35000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.146 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.138 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.107 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 3.564 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.971 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.955 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 2889 ; 0.005 ; 0.012 REMARK 3 BOND LENGTHS OTHERS (A): 2732 ; 0.001 ; 0.017 REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 3921 ; 1.225 ; 1.653 REMARK 3 BOND ANGLES OTHERS (DEGREES): 6188 ; 0.435 ; 1.584 REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 333 ; 6.248 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 177 ;30.281 ;21.130 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 492 ;13.547 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 25 ;21.235 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 348 ; 0.065 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 3223 ; 0.006 ; 0.020 REMARK 3 GENERAL PLANES OTHERS (A): 746 ; 0.001 ; 0.020 REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : MASK REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.20 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN USED IF PRESENT IN REMARK 3 THE INPUT U VALUES : REFINED INDIVIDUALLY REMARK 4 REMARK 4 7L1X COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 16-DEC-20. REMARK 100 THE DEPOSITION ID IS D_1000253562. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 21-JUN-11 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 7.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : APS REMARK 200 BEAMLINE : 23-ID-D REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.98011 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : MAR CCD 165 MM REMARK 200 INTENSITY-INTEGRATION SOFTWARE : HKL-2000 REMARK 200 DATA SCALING SOFTWARE : HKL-2000 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 28233 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.800 REMARK 200 RESOLUTION RANGE LOW (A) : 25.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 97.3 REMARK 200 DATA REDUNDANCY : 3.900 REMARK 200 R MERGE (I) : 0.09100 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 18.5100 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.80 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.84 REMARK 200 COMPLETENESS FOR SHELL (%) : NULL REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : 0.50000 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: 3OWJ REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 38.05 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 1.99 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 100 MM TRIS-HCL PH 7.5 200 MM AMMONIUM REMARK 280 SULFATE 21% PEG5000, VAPOR DIFFUSION, HANGING DROP, TEMPERATURE REMARK 280 293K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 21 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 22.99050 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 SER A 2 REMARK 465 GLN A 331 REMARK 465 ALA A 332 REMARK 465 ARG A 333 REMARK 465 MET A 334 REMARK 465 GLY A 335 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 GLU A 32 CG CD OE1 OE2 REMARK 470 VAL A 73 CG1 CG2 REMARK 470 LYS A 74 CG CD CE NZ REMARK 470 LYS A 75 CG CD CE NZ REMARK 470 LYS A 102 CE NZ REMARK 470 LYS A 122 CG CD CE NZ REMARK 470 GLN A 123 CG CD OE1 NE2 REMARK 470 ASP A 330 CG OD1 OD2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 HD1 HIS A 321 H TYR A 323 1.30 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ASN A 61 -0.01 -145.41 REMARK 500 VAL A 73 -106.14 -94.88 REMARK 500 ASP A 156 45.30 -147.50 REMARK 500 ASP A 175 76.27 51.95 REMARK 500 ALA A 193 160.66 65.75 REMARK 500 MET A 208 58.18 -93.39 REMARK 500 HIS A 234 70.61 -109.57 REMARK 500 REMARK 500 REMARK: NULL REMARK 615 REMARK 615 ZERO OCCUPANCY ATOM REMARK 615 THE FOLLOWING RESIDUES HAVE ATOMS MODELED WITH ZERO REMARK 615 OCCUPANCY. THE LOCATION AND PROPERTIES OF THESE ATOMS REMARK 615 MAY NOT BE RELIABLE. (M=MODEL NUMBER; RES=RESIDUE NAME; REMARK 615 C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE): REMARK 615 M RES C SSEQI REMARK 615 ON6 A 406 REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue SO4 A 401 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue SO4 A 402 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue SO4 A 403 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue SO4 A 404 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC5 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue GOL A 405 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC6 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue ON6 A 406 DBREF 7L1X A 2 335 UNP P68400 CSK21_HUMAN 2 335 SEQRES 1 A 334 SER GLY PRO VAL PRO SER ARG ALA ARG VAL TYR THR ASP SEQRES 2 A 334 VAL ASN THR HIS ARG PRO ARG GLU TYR TRP ASP TYR GLU SEQRES 3 A 334 SER HIS VAL VAL GLU TRP GLY ASN GLN ASP ASP TYR GLN SEQRES 4 A 334 LEU VAL ARG LYS LEU GLY ARG GLY LYS TYR SER GLU VAL SEQRES 5 A 334 PHE GLU ALA ILE ASN ILE THR ASN ASN GLU LYS VAL VAL SEQRES 6 A 334 VAL LYS ILE LEU LYS PRO VAL LYS LYS LYS LYS ILE LYS SEQRES 7 A 334 ARG GLU ILE LYS ILE LEU GLU ASN LEU ARG GLY GLY PRO SEQRES 8 A 334 ASN ILE ILE THR LEU ALA ASP ILE VAL LYS ASP PRO VAL SEQRES 9 A 334 SER ARG THR PRO ALA LEU VAL PHE GLU HIS VAL ASN ASN SEQRES 10 A 334 THR ASP PHE LYS GLN LEU TYR GLN THR LEU THR ASP TYR SEQRES 11 A 334 ASP ILE ARG PHE TYR MET TYR GLU ILE LEU LYS ALA LEU SEQRES 12 A 334 ASP TYR CYS HIS SER MET GLY ILE MET HIS ARG ASP VAL SEQRES 13 A 334 LYS PRO HIS ASN VAL MET ILE ASP HIS GLU HIS ARG LYS SEQRES 14 A 334 LEU ARG LEU ILE ASP TRP GLY LEU ALA GLU PHE TYR HIS SEQRES 15 A 334 PRO GLY GLN GLU TYR ASN VAL ARG VAL ALA SER ARG TYR SEQRES 16 A 334 PHE LYS GLY PRO GLU LEU LEU VAL ASP TYR GLN MET TYR SEQRES 17 A 334 ASP TYR SER LEU ASP MET TRP SER LEU GLY CYS MET LEU SEQRES 18 A 334 ALA SER MET ILE PHE ARG LYS GLU PRO PHE PHE HIS GLY SEQRES 19 A 334 HIS ASP ASN TYR ASP GLN LEU VAL ARG ILE ALA LYS VAL SEQRES 20 A 334 LEU GLY THR GLU ASP LEU TYR ASP TYR ILE ASP LYS TYR SEQRES 21 A 334 ASN ILE GLU LEU ASP PRO ARG PHE ASN ASP ILE LEU GLY SEQRES 22 A 334 ARG HIS SER ARG LYS ARG TRP GLU ARG PHE VAL HIS SER SEQRES 23 A 334 GLU ASN GLN HIS LEU VAL SER PRO GLU ALA LEU ASP PHE SEQRES 24 A 334 LEU ASP LYS LEU LEU ARG TYR ASP HIS GLN SER ARG LEU SEQRES 25 A 334 THR ALA ARG GLU ALA MET GLU HIS PRO TYR PHE TYR THR SEQRES 26 A 334 VAL VAL LYS ASP GLN ALA ARG MET GLY HET SO4 A 401 5 HET SO4 A 402 5 HET SO4 A 403 5 HET SO4 A 404 5 HET GOL A 405 14 HET ON6 A 406 48 HETNAM SO4 SULFATE ION HETNAM GOL GLYCEROL HETNAM ON6 (2~{Z})-6-[[2,6-BIS(CHLORANYL)PHENYL]METHYLSULFONYL]-2- HETNAM 2 ON6 [[4-OXIDANYL-3-[OXIDANYL(OXIDANYLIDENE)-$L^{4}- HETNAM 3 ON6 AZANYL]PHENYL]METHYLIDENE]-4~{H}-1,4-BENZOTHIAZIN-3- HETNAM 4 ON6 ONE HETSYN GOL GLYCERIN; PROPANE-1,2,3-TRIOL FORMUL 2 SO4 4(O4 S 2-) FORMUL 6 GOL C3 H8 O3 FORMUL 7 ON6 C22 H15 CL2 N2 O6 S2 FORMUL 8 HOH *221(H2 O) HELIX 1 AA1 VAL A 15 ARG A 19 5 5 HELIX 2 AA2 PRO A 20 ASP A 25 1 6 HELIX 3 AA3 TYR A 26 HIS A 29 5 4 HELIX 4 AA4 ASN A 35 ASP A 37 5 3 HELIX 5 AA5 LYS A 75 ARG A 89 1 15 HELIX 6 AA6 ASP A 120 GLN A 126 1 7 HELIX 7 AA7 THR A 129 MET A 150 1 22 HELIX 8 AA8 LYS A 158 HIS A 160 5 3 HELIX 9 AA9 ASP A 175 ALA A 179 5 5 HELIX 10 AB1 SER A 194 LYS A 198 5 5 HELIX 11 AB2 GLY A 199 VAL A 204 1 6 HELIX 12 AB3 TYR A 211 ARG A 228 1 18 HELIX 13 AB4 ASP A 237 GLY A 250 1 14 HELIX 14 AB5 GLY A 250 TYR A 261 1 12 HELIX 15 AB6 ASP A 266 ILE A 272 5 7 HELIX 16 AB7 ARG A 280 VAL A 285 5 6 HELIX 17 AB8 ASN A 289 VAL A 293 5 5 HELIX 18 AB9 SER A 294 LEU A 305 1 12 HELIX 19 AC1 ASP A 308 ARG A 312 5 5 HELIX 20 AC2 THR A 314 GLU A 320 1 7 HELIX 21 AC3 HIS A 321 TYR A 325 5 5 SHEET 1 AA1 5 TYR A 39 ARG A 47 0 SHEET 2 AA1 5 SER A 51 ASN A 58 -1 O VAL A 53 N LEU A 45 SHEET 3 AA1 5 LYS A 64 LEU A 70 -1 O ILE A 69 N GLU A 52 SHEET 4 AA1 5 PRO A 109 GLU A 114 -1 O LEU A 111 N LYS A 68 SHEET 5 AA1 5 LEU A 97 LYS A 102 -1 N VAL A 101 O ALA A 110 SHEET 1 AA2 2 ILE A 152 MET A 153 0 SHEET 2 AA2 2 GLU A 180 PHE A 181 -1 O GLU A 180 N MET A 153 SHEET 1 AA3 2 VAL A 162 ASP A 165 0 SHEET 2 AA3 2 LYS A 170 LEU A 173 -1 O ARG A 172 N MET A 163 CISPEP 1 GLU A 230 PRO A 231 0 -12.93 SITE 1 AC1 4 ARG A 191 LYS A 198 ASN A 238 HOH A 501 SITE 1 AC2 7 ASP A 253 ARG A 278 ARG A 306 TYR A 307 SITE 2 AC2 7 ASP A 308 HOH A 544 HOH A 645 SITE 1 AC3 4 LYS A 229 HIS A 234 ARG A 244 HOH A 617 SITE 1 AC4 5 LYS A 76 ARG A 80 ARG A 155 ASN A 189 SITE 2 AC4 5 VAL A 192 SITE 1 AC5 2 LYS A 75 LYS A 76 SITE 1 AC6 8 VAL A 66 LYS A 68 PHE A 113 VAL A 116 SITE 2 AC6 8 ASN A 118 ILE A 174 ASP A 175 HOH A 524 CRYST1 58.348 45.981 63.683 90.00 111.84 90.00 P 1 21 1 2 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.017139 0.000000 0.006867 0.00000 SCALE2 0.000000 0.021748 0.000000 0.00000 SCALE3 0.000000 0.000000 0.016916 0.00000